Cargando…

A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy—A Systematic Review and Meta-Analysis

The increase in life expectancy without a decrease in the years lived without disability leads to the rise of the population aged over 65 years prone to polypharmacy. The novel antidiabetic drugs can improve this global therapeutic and health problem in patients with diabetes mellitus (DM). We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salmen, Teodor, Serbanoiu, Liviu-Ionut, Bica, Ioana-Cristina, Serafinceanu, Cristian, Muzurović, Emir, Janez, Andrej, Busnatu, Stefan, Banach, Maciej, Rizvi, Ali Abbas, Rizzo, Manfredi, Pantea Stoian, Anca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253587/ https://www.ncbi.nlm.nih.gov/pubmed/37298707 http://dx.doi.org/10.3390/ijms24119760

Ejemplares similares

The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
por: Bica, Ioana-Cristina, et al.
Publicado: (2023)

Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus—A Real-Life Clinical Practice Study
por: Salmen, Teodor, et al.
Publicado: (2023)

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
por: Popovic, Djordje S., et al.
Publicado: (2021)

Non-Insulin Novel Antidiabetic Drugs Mechanisms in the Pathogenesis of COVID-19
por: Salmen, Teodor, et al.
Publicado: (2022)

The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus—A Systematic Review
por: Bica, Ioana-Cristina, et al.
Publicado: (2023)

Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
por: Rizvi, Ali A., et al.
Publicado: (2021)

Effects of Exercise in Improving Cardiometabolic Risk Factors in Overweight Children: A Systematic Review and Meta-Analysis
por: Busnatu, Stefan Sebastian, et al.
Publicado: (2022)

The Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists in the Standard of Care Treatment of Type 2 Diabetes Mellitus
por: Salmen, Teodor, et al.
Publicado: (2023)

The Role of Fructose as a Cardiovascular Risk Factor: An Update
por: Busnatu, Stefan-Sebastian, et al.
Publicado: (2022)

Correlations between Diabetes Mellitus Self-Care Activities and Glycaemic Control in the Adult Population: A Cross-Sectional Study
por: Popoviciu, Mihaela Simona, et al.
Publicado: (2022)

Transcatheter Aortic Valve Replacement vs. Surgical Aortic Valve Replacement for Long-Term Mortality Due to Stroke and Myocardial Infarction: A Meta-Analysis during the COVID-19 Pandemic
por: Ion, Alexandru Cristian, et al.
Publicado: (2022)

Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
por: Rizvi, Ali Abbas, et al.
Publicado: (2021)

Evaluating the Adipose Tissue Depth as a Predictor Factor for Gestational Diabetes in Later Pregnancy—A Systematic Review
por: Salmen, Bianca-Margareta, et al.
Publicado: (2023)

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
por: Janić, Miodrag, et al.
Publicado: (2022)

Higher Mortality Associated With New-Onset Atrial Fibrillation in Cancer Patients: A Systematic Review and Meta-Analysis
por: Murtaza, Minha, et al.
Publicado: (2022)

The Bidirectional Relationship between Periodontal Disease and Diabetes Mellitus—A Review
por: Păunică, Ioana, et al.
Publicado: (2023)

A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies
por: Vekic, Jelena, et al.
Publicado: (2022)

Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care
por: Rizvi, Ali A., et al.
Publicado: (2021)

Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL
por: Vekic, Jelena, et al.
Publicado: (2022)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

COVID-19 and diabetes management: What should be considered?
por: Ceriello, Antonio, et al.
Publicado: (2020)

Novel Therapeutical Approaches to Managing Atherosclerotic Risk
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2021)

Interleukin-8, CXCL10, CXCL11 and their role in insulin resistance in adult females with subclinical hypothyroidism and prediabetes
por: Stoica, Roxana Adriana, et al.
Publicado: (2022)

Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL
por: Vekic, Jelena, et al.
Publicado: (2022)

No Association between 25-Hydroxyvitamin D and Insulin Resistance or Thyroid Hormone Concentrations in a Romanian Observational Study
por: Stoica, Roxana Adriana, et al.
Publicado: (2020)

Timing Is Important—Management of Metabolic Syndrome According to the Circadian Rhythm
por: Zečević, Ksenija, et al.
Publicado: (2023)

Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study
por: Nikolic, Dragana, et al.
Publicado: (2022)

Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues
por: Rizvi, Ali A., et al.
Publicado: (2021)

Editorial: Diet-microbe-host interactions in metabolic syndrome
por: Gradisteanu Pircalabioru, Gratiela, et al.
Publicado: (2023)

CERN's newest building
por: Anaïs Vernède
Publicado: (2011)

The Newest of Our Creeds
por: Hodgkin,
Publicado: (1881)

The Newest of Our Creeds
Publicado: (1878)

Influenza’s Newest Trick
por: Taubenberger, Jeffery K.
Publicado: (2019)

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Novel Biomarkers Predictive of Diabetic Charcot Foot—An Overview of the Literature
por: Bobircă, Anca, et al.
Publicado: (2022)

Newest results from the EMC
por: Janata, F
Publicado: (1987)

Non-alcoholic fatty liver disease in diabetes mellitus patients on chronic hemodialysis – A case series addressing cardiovascular and mortality risks
por: Stoica, Roxana Adriana, et al.
Publicado: (2023)

Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions
por: Sivani, Bala Mohan, et al.
Publicado: (2022)

Oral Arginine Supplementation in Healthy Individuals Performing Regular Resistance Training
por: Busnatu, Ștefan-Sebastian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_36dhhccmd70che7oojnvv0qhvf